Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
After Yesterday's Decline of 2.43%, Idexx Labs Offers Investors Better Value

Idexx Labs (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $384.19 to a high of $395.74. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $385.22...

IDXX : 381.76 (-2.06%)
IDEXX Laboratories Announces Second Quarter Results

, /PRNewswire/ --

IDXX : 381.76 (-2.06%)
Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?

Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

IDXX : 381.76 (-2.06%)
CERN : 70.04 (+0.13%)
FMS : 42.93 (-0.85%)
RMD : 173.24 (-1.30%)
IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise

IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.

PKI : 119.33 (+0.24%)
TMO : 414.33 (-0.34%)
WST : 273.55 (-0.12%)
IDXX : 381.76 (-2.06%)
Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?

Is (IDXX) Outperforming Other Medical Stocks This Year?

IDXX : 381.76 (-2.06%)
Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

IDXX : 381.76 (-2.06%)
Idexx: 2Q Earnings Snapshot

WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported second-quarter profit of $148.9 million.

IDXX : 381.76 (-2.06%)
Will Epidolex Drive GW Pharmaceuticals' (GWPH) Q2 Earnings?

Amid the pandemic situation, GW Pharmaceuticals (GWPH), which controls its own manufacture and supply chain, is expected to have faced minimum supply-related disruption unlike others.

IART : 48.09 (+0.59%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
GWPH : 109.37 (-17.21%)
Illumina (ILMN) to Report Q2 Earnings: What's in the Offing?

Illumina (ILMN) is upbeat about its second-quarter sequencing consumable revenue growth.

ILMN : 355.66 (-10.94%)
LMNX : 32.06 (-3.20%)
IART : 48.09 (+0.59%)
IDXX : 381.76 (-2.06%)
Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?

IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

IDXX : 381.76 (-2.06%)
What's in the Cards for CVS Health (CVS) in Q2 Earnings?

CVS Health's (CVS) consumer centric digital strategy becomes even more relevant in Q2 with people increasingly using technology while staying at home.

IART : 48.09 (+0.59%)
CVS : 64.96 (+1.31%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
STAAR Surgical (STAA) to Report Q2 Earnings: What's in Store?

STAAR Surgical's (STAA) ICL line of products is likely to have boosted Q2 performance amid the coronavirus pandemic.

IART : 48.09 (+0.59%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
STAA : 54.16 (-3.04%)
STERIS (STE) to Report Q1 Earnings: What's in the Cards?

STERIS (STE) registers declines in Healthcare Products with neutral performance in Life Science and AST in April, which is likely to have impacted Q1 earnings.

IART : 48.09 (+0.59%)
STE : 154.22 (-1.13%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
Zimmer Biomet (ZBH) to Report Q2 Earnings: What's in Store?

Zimmer Biomet's (ZBH) Hips and Knees portfolios are expected to have contributed to second-quarter top line despite pandemic-led business disruptions.

IART : 48.09 (+0.59%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
ZBH : 139.38 (+4.80%)
Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

Henry Schein's (HSIC) medical business' PPE sales are likely to have boosted Q2 performance amid the coronavirus pandemic.

IART : 48.09 (+0.59%)
HSIC : 67.80 (+1.22%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?

IDEXX's (IDXX) top line is likely to have benefited from a robust CAG business and regulatory approvals for its COVID-19 tests.

IART : 48.09 (+0.59%)
LH : 193.11 (+1.76%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
69.5% Return Seen to Date on SmarTrend Idexx Labs Call (IDXX)

SmarTrend identified an Uptrend for Idexx Labs (NASDAQ:IDXX) on March 25th, 2020 at $212.26. In approximately 4 months, Idexx Labs has returned 69.45% as of today's recent price of $359.67.

IDXX : 381.76 (-2.06%)
Deferred Procedures to Mar Boston Scientific (BSX) Q2 Earnings

With lockdowns continuing through all three months of the second quarter, Boston Scientific (BSX) is expected to have faced a more dreadful time.

IART : 48.09 (+0.59%)
BSX : 38.97 (+2.85%)
IDXX : 381.76 (-2.06%)
EXAS : 86.69 (-4.10%)
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

IDXX : 381.76 (-2.06%)
Are You Looking for a Top Momentum Pick? Why Idexx Laboratories (IDXX) is a Great Choice

Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.

IDXX : 381.76 (-2.06%)

Van Meerten Stock Picks

The 5 Best MidCaps
I wanted to find the 5 Mid Caps that have had the best momentum over the past year so I used Barchart to sort the S&P 400 MidCap Stock Index for the stocks with the highest Weighted Alpha and technical buying signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar